• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于新冠病毒XBB.1.5流行病学传播的分子深度研究

Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5.

作者信息

Scarpa Fabio, Azzena Ilenia, Locci Chiara, Casu Marco, Fiori Pier Luigi, Ciccozzi Alessandra, Angeletti Silvia, Imperia Elena, Giovanetti Marta, Maruotti Antonello, Borsetti Alessandra, Cauda Roberto, Cassone Antonio, Via Allegra, Pascarella Stefano, Sanna Daria, Ciccozzi Massimo

机构信息

Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.

Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy.

出版信息

Microorganisms. 2023 Mar 31;11(4):912. doi: 10.3390/microorganisms11040912.

DOI:10.3390/microorganisms11040912
PMID:37110335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10142263/
Abstract

Since the beginning of the pandemic, the generation of new variants periodically recurs. The XBB.1.5 SARS-CoV-2 variant is one of the most recent. This research was aimed at verifying the potential hazard of this new subvariant. To achieve this objective, we performed a genome-based integrative approach, integrating results from genetic variability/phylodynamics with structural and immunoinformatic analyses to obtain as comprehensive a viewpoint as possible. The Bayesian Skyline Plot (BSP) shows that the viral population size reached the plateau phase on 24 November 2022, and the number of lineages peaked at the same time. The evolutionary rate is relatively low, amounting to 6.9 × 10 subs/sites/years. The NTD domain is identical for XBB.1 and XBB.1.5 whereas their RBDs only differ for the mutations at position 486, where the Phe (in the original Wuhan) is replaced by a Ser in XBB and XBB.1, and by a Pro in XBB.1.5. The variant XBB.1.5 seems to spread more slowly than sub-variants that have caused concerns in 2022. The multidisciplinary molecular in-depth analyses on XBB.1.5 performed here does not provide evidence for a particularly high risk of viral expansion. Results indicate that XBB.1.5 does not possess features to become a new, global, public health threat. As of now, in its current molecular make-up, XBB.1.5 does not represent the most dangerous variant.

摘要

自疫情开始以来,新变种的产生周期性地反复出现。XBB.1.5新冠病毒变种是最新的变种之一。本研究旨在验证这种新亚变种的潜在危害。为实现这一目标,我们采用了基于基因组的综合方法,将遗传变异性/系统发育动力学结果与结构和免疫信息学分析结果相结合,以尽可能获得全面的观点。贝叶斯天际线图(BSP)显示,病毒种群数量在2022年11月24日达到平稳期,谱系数量同时达到峰值。进化速率相对较低,为6.9×10⁻⁴个替换/位点/年。XBB.1和XBB.1.5的NTD结构域相同,而它们的RBD仅在486位的突变上有所不同,在该位置,苯丙氨酸(原始武汉株)在XBB和XBB.1中被丝氨酸取代,在XBB.1.5中被脯氨酸取代。XBB.1.5变种的传播速度似乎比2022年引起关注的亚变种更慢。此处对XBB.1.5进行的多学科分子深入分析并未提供病毒扩张特别高风险的证据。结果表明,XBB.1.5不具备成为新的全球公共卫生威胁的特征。截至目前,就其当前的分子构成而言,XBB.1.5并不代表最危险的变种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/362be2724327/microorganisms-11-00912-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/c204dd990cff/microorganisms-11-00912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/69e691b527fe/microorganisms-11-00912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/6115665f1fba/microorganisms-11-00912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/abe1ca756240/microorganisms-11-00912-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/362be2724327/microorganisms-11-00912-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/c204dd990cff/microorganisms-11-00912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/69e691b527fe/microorganisms-11-00912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/6115665f1fba/microorganisms-11-00912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/abe1ca756240/microorganisms-11-00912-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd86/10142263/362be2724327/microorganisms-11-00912-g005.jpg

相似文献

1
Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5.关于新冠病毒XBB.1.5流行病学传播的分子深度研究
Microorganisms. 2023 Mar 31;11(4):912. doi: 10.3390/microorganisms11040912.
2
Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant.基于整合基因组的 SARS-CoV-2 奥密克戎 XBB.1.16 变体调查。
Int J Mol Sci. 2023 Sep 1;24(17):13573. doi: 10.3390/ijms241713573.
3
Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages.基于基因组的重组严重急性呼吸综合征冠状病毒2(SARS-CoV-2)XBB与其亲本谱系之间的比较。
J Med Virol. 2023 Mar;95(3):e28625. doi: 10.1002/jmv.28625.
4
Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.社论:奥密克戎 SARS-CoV-2 的 XBB.1.5(“Kraken”)亚变体及其快速全球传播。
Med Sci Monit. 2023 Feb 1;29:e939580. doi: 10.12659/MSM.939580.
5
Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion.SARS-CoV-2 奥密克戎 BQ.1 变体的遗传和结构数据表明其在流行病学上的扩展潜力较低。
Int J Mol Sci. 2022 Dec 3;23(23):15264. doi: 10.3390/ijms232315264.
6
Dynamics of SARS-CoV-2 variants during the XBB wave in the Republic of Korea.韩国XBB波期间新型冠状病毒变异株的动态变化。
Virus Res. 2024 Dec;350:199471. doi: 10.1016/j.virusres.2024.199471. Epub 2024 Sep 25.
7
Genome-based survey of the SARS-CoV-2 BF.7 variant from Asia.基于基因组的亚洲新冠病毒BF.7变异株调查。
J Med Virol. 2023 Apr;95(4):e28714. doi: 10.1002/jmv.28714.
8
Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?新冠病毒XBB奥密克戎亚变体是否预示着大流行结束的开始?
Singapore Med J. 2024 Dec 1;65(12):658-664. doi: 10.4103/singaporemedj.SMJ-2022-180. Epub 2022 Dec 1.
9
XBB.1.5 Kraken cracked: Gibbs energies of binding and biosynthesis of the XBB.1.5 variant of SARS-CoV-2.XBB.1.5 Kraken 破解:SARS-CoV-2 的 XBB.1.5 变体的结合和生物合成的吉布斯自由能。
Microbiol Res. 2023 May;270:127337. doi: 10.1016/j.micres.2023.127337. Epub 2023 Feb 15.
10
Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage.2022年10月至11月意大利SARS-CoV-2变体的废水监测:XBB.1、BA.2.75的检测以及BQ.1谱系的快速传播
Sci Total Environ. 2023 May 15;873:162339. doi: 10.1016/j.scitotenv.2023.162339. Epub 2023 Feb 21.

引用本文的文献

1
SARS-CoV-2 XEC: A Genome-Based Survey.严重急性呼吸综合征冠状病毒2型XEC:一项基于基因组的调查。
Microorganisms. 2025 Jan 24;13(2):253. doi: 10.3390/microorganisms13020253.
2
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement.区分XBB.1和XBB.1.5的单峰突变增强了新冠病毒的细胞间传播并促进了血清介导的增强作用。
Front Immunol. 2024 Nov 27;15:1501200. doi: 10.3389/fimmu.2024.1501200. eCollection 2024.
3
Update of the Genetic Variability of Monkeypox Virus Clade IIb Lineage B.1.

本文引用的文献

1
Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage.基于基因和结构基因组的调查揭示了新冠病毒XBB.1.5亚谱系在流行病学上的低传播潜力。
J Infect. 2023 Jun;86(6):596-598. doi: 10.1016/j.jinf.2023.02.039. Epub 2023 Mar 1.
2
Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages.基于基因组的重组严重急性呼吸综合征冠状病毒2(SARS-CoV-2)XBB与其亲本谱系之间的比较。
J Med Virol. 2023 Mar;95(3):e28625. doi: 10.1002/jmv.28625.
3
XBB.1.5 Kraken cracked: Gibbs energies of binding and biosynthesis of the XBB.1.5 variant of SARS-CoV-2.
猴痘病毒IIb分支B.1的遗传变异性更新
Microorganisms. 2024 Sep 11;12(9):1874. doi: 10.3390/microorganisms12091874.
4
Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of Omicron (B1.1.529) pseudovirus.抗生素达托霉素与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的S蛋白相互作用,以促进奥密克戎(B1.1.529)假病毒的细胞侵袭。
Virulence. 2024 Dec;15(1):2339703. doi: 10.1080/21505594.2024.2339703. Epub 2024 Apr 24.
5
Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022-August 2023.2022 年 12 月至 2023 年 8 月期间泰国曼谷 SARS-CoV-2 奥密克戎变异株 XBB.1.16 优势流行期的基因组流行病学和进化分析。
Sci Rep. 2024 Jan 5;14(1):645. doi: 10.1038/s41598-023-50856-0.
6
Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant.基于整合基因组的 SARS-CoV-2 奥密克戎 XBB.1.16 变体调查。
Int J Mol Sci. 2023 Sep 1;24(17):13573. doi: 10.3390/ijms241713573.
7
Early Detection of the Recombinant SARS-CoV-2 XAN Variant in Bulgaria: Initial Genomic Insights into Yet Another Piece of the Growing Puzzle of Recombinant Clades.保加利亚对重组严重急性呼吸综合征冠状病毒2型XAN变体的早期检测:对重组分支这一日益复杂难题的又一部分的初步基因组见解。
Microorganisms. 2023 Aug 9;11(8):2041. doi: 10.3390/microorganisms11082041.
8
An ARMS-Multiplex PCR Targeting SARS-CoV-2 Omicron Sub-Variants.一种靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎亚变体的扩增不应变突变系统多重聚合酶链反应(ARMS-Multiplex PCR)
Pathogens. 2023 Aug 6;12(8):1017. doi: 10.3390/pathogens12081017.
9
Dissemination of the Omicron Variant and Its Sub-Lineages among Residents and Travelers in Its First Year of Emergence in Venezuela.奥密克戎变异株及其子谱系在委内瑞拉出现的第一年在居民和旅行者中的传播。
Viruses. 2023 Jun 28;15(7):1460. doi: 10.3390/v15071460.
10
SARS-CoV-2 Recombinants: Genomic Comparison between XBF and Its Parental Lineages.严重急性呼吸综合征冠状病毒2重组体:XBF与其亲本谱系之间的基因组比较。
Microorganisms. 2023 Jul 17;11(7):1824. doi: 10.3390/microorganisms11071824.
XBB.1.5 Kraken 破解:SARS-CoV-2 的 XBB.1.5 变体的结合和生物合成的吉布斯自由能。
Microbiol Res. 2023 May;270:127337. doi: 10.1016/j.micres.2023.127337. Epub 2023 Feb 15.
4
ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5.XBB.1.5增强传播性中的ACE2结合与抗体逃逸
Lancet Infect Dis. 2023 Mar;23(3):278-280. doi: 10.1016/S1473-3099(23)00010-5. Epub 2023 Feb 3.
5
Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.社论:奥密克戎 SARS-CoV-2 的 XBB.1.5(“Kraken”)亚变体及其快速全球传播。
Med Sci Monit. 2023 Feb 1;29:e939580. doi: 10.12659/MSM.939580.
6
XBB.1.5 emerges in the Americas: what it means to the region.XBB.1.5毒株在美洲出现:这对该地区意味着什么。
Lancet Reg Health Am. 2023 Feb;18:100433. doi: 10.1016/j.lana.2023.100433. Epub 2023 Jan 24.
7
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants.在 SARS-CoV-2 变异株中,普遍存在且免疫优势的 CD8 T 细胞表位是保守的。
Cell Rep. 2023 Jan 31;42(1):111995. doi: 10.1016/j.celrep.2023.111995. Epub 2023 Jan 9.
8
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.令人担忧的 SARS-CoV-2 BQ 和 XBB 亚型不断出现的抗体逃逸特性。
Cell. 2023 Jan 19;186(2):279-286.e8. doi: 10.1016/j.cell.2022.12.018. Epub 2022 Dec 14.
9
Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion.SARS-CoV-2 奥密克戎 BQ.1 变体的遗传和结构数据表明其在流行病学上的扩展潜力较低。
Int J Mol Sci. 2022 Dec 3;23(23):15264. doi: 10.3390/ijms232315264.
10
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.抗病毒药物对奥密克戎亚型BQ.1.1和XBB的疗效
N Engl J Med. 2023 Jan 5;388(1):89-91. doi: 10.1056/NEJMc2214302. Epub 2022 Dec 7.